NDC product
Labetalol Hydrochloride
NDC 24979-170 · TWi Pharmaceuticals, Inc.
Key facts
| Product NDC | 24979-170 |
|---|---|
| Proprietary name | Labetalol Hydrochloride |
| Labeler | TWi Pharmaceuticals, Inc. |
| Marketing category | ANDA |
| Application number | ANDA209603 |
| Marketing start | Aug 1, 2018 |
| Marketing end | Dec 24, 2021 |
| Listing certified through | Dec 24, 2021 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: